TGFB3 and pulmonary arterial hypertension: More selective methods of TGF-β inhibition, including a pan anti–TGF-β antibody and a TGFBRII-Fc fusion protein that selectively sequesters TGF-β1 and TGF-β3, have displayed efficacy in rodent models of PAH (57, 63).